Cost-benefit analysis of surveillance for surgical site infection following caesarean section

BMJ Open. 2020 Jul 20;10(7):e036919. doi: 10.1136/bmjopen-2020-036919.

Abstract

Objective: To estimate the economic burden to the health service of surgical site infection following caesarean section and to identify potential savings achievable through implementation of a surveillance programme.

Design: Economic model to evaluate the costs and benefits of surveillance from community and hospital healthcare providers' perspective.

Setting: England.

Participants: Women undergoing caesarean section in National Health Service hospitals.

Main outcome measure: Costs attributable to treatment and management of surgical site infection following caesarean section.

Results: The costs (2010) for a hospital carrying out 800 caesarean sections a year based on infection risk of 9.6% were estimated at £18 914 (95% CI 11 521 to 29 499) with 28% accounted for by community care (£5370). With inflation to 2019 prices, this equates to an estimated cost of £5.0 m for all caesarean sections performed annually in England 2018-2019, approximately £1866 and £93 per infection managed in hospital and community, respectively. The cost of surveillance for a hospital for one calendar quarter was estimated as £3747 (2010 costs). Modelling a decrease in risk of infection of 30%, 20% or 10% between successive surveillance periods indicated that a variable intermittent surveillance strategy achieved higher or similar net savings than continuous surveillance. Breakeven was reached sooner with the variable surveillance strategy than continuous surveillance when the baseline risk of infection was 10% or 15% and smaller loses with a baseline risk of 5%.

Conclusion: Surveillance of surgical site infections after caesarean section with feedback of data to surgical teams offers a potentially effective means to reduce infection risk, improve patient experience and save money for the health service.

Keywords: epidemiology; health economics; maternal medicine.

MeSH terms

  • Cesarean Section* / adverse effects
  • Cost-Benefit Analysis
  • England / epidemiology
  • Female
  • Humans
  • Pregnancy
  • State Medicine
  • Surgical Wound Infection* / epidemiology